Skip to content

The effect of phenobarbital on the outcome of early ischemic encephalopathy Hypoxemic

The effect of phenobarbital on the outcome of early ischemic encephalopathy Hypoxemic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014090919101N1
Enrollment
30
Registered
2014-09-17
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxic ischaemic encephalopathy of newborn. Hypoxic ischaemic encephalopathy of newborn, unspecified

Interventions

Intervention 1: The first group receive 20 mg/kg intravenous phenobarbital within 6 hours of birth. Intervention 2: The second group not receive additional doses of phenobarbital.
Treatment - Drugs
The first group receive 20 mg/kg intravenous phenobarbital within 6 hours of birth
The second group not receive additional doses of phenobarbital

Sponsors

Vice chancellor for research of Shahrekord University of Medical Scie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 1 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 38 and 42 weeks; Five-minute Apgar score less than 3 at birth or delay in breathing for more than 5 minutes after birth; lethargy; seizures; abnormal neonatal reflexes; hypotonia in the early stages of birth Exclusion criteria: two twins; Congenital malformations; Chromosomal abnormalities; Congenital infection or Koryoamnyotit; ); Encephalopathy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduction of Nitric oxide level. Timepoint: A week later. Method of measurement: sampling.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPanahandeh Gholamreza

Shahrekord University of Medical Sciences

gholamrezapanahandeh@gmail.com+98 38 1333 0065

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026